# Arterys

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arterys

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.arterys.com
- Total disclosed funding: $67M
- Latest round: Series C (Apr 28, 2020)
- Investors on record: 17

## About

Based in San Francisco, Arterys is a cloud-based medical imaging company that leverages advanced AI technology to enhance diagnostic capabilities for healthcare providers.Arterys, Inc. specializes in providing cloud-based medical imaging solutions. Founded in 2013 by Albert Hsiao, Miyoshi Aki, and Shreyas Vasanawala, the company has pivoted to focus on integrating AI into healthcare. The headquarters is located in San Francisco, US. The company raised USD 24.39 mn in Series C funding on April 28, 2020, co-led by Benslie Investment Group and Temasek Holdings, alongside other investors. The total amount raised by Arterys to date is USD 24.39 mn, with a current company valuation of USD 48.575 mn.Arterys specializes in cloud-based medical imaging AI solutions designed to enhance the diagnostic capabilities of healthcare providers. Their primary offering is a platform that integrates advanced artificial intelligence applications into existing Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHR). The technology extracts actionable insights from medical images, improving diagnostic accuracy and enhancing clinical decision-making. Arterys serves hospitals, imaging centers, and research institutions across North America and Europe, enabling access to their solutions from any validated device without requiring patient health information exchange.Arterys generates revenue through a subscription-based model for its AI medical imaging platform, primarily targeting healthcare providers. Clients typically enter multi-year agreements including software licensing, training, and ongoing support. The revenue model focuses on B2B transactions with hospitals and healthcare networks. Pricing plans are tailored to individual client needs based on deployment scale and service range, with flagship offerings that facilitate improved analysis of radiology scans.Arterys plans to utilize the recent Series C funding of USD 24.39 mn to further develop its AI medical imaging technology and expand into new markets. The company is particularly focused on launching new product features to enhance their platform's capabilities, with targeted expansion into additional regions in Europe and Asia by late 2023. The funding will support the ramp-up of research and development efforts to facilitate these initiatives.

## Funding rounds

- Series C, Apr 28, 2020, $24M — Temasek Holdings, Emergent Medical Ventures, Varian Medical Systems, Inc., Revelation Partners, Fosun Capital, Benslie Investment Group
- Series B, Nov 3, 2017, $30M — Temasek Holdings, Emergent Medical Ventures, Varian Medical Systems, Inc., Fosun Capital, Northwell Holdings, GE Ventures, ORI Capital, NewYork-Presbyterian Hospital, DNA Capital
- Series A, Mar 14, 2016, $5M — GE Capital, Equity, Emergent Medical Ventures, Asset Management Ventures, Morado Ventures, Norwich Ventures, AME Cloud Ventures, Stanford-StartX Fund
- Series A, Nov 9, 2015, $7.1M — Emergent Medical Ventures, Asset Management Ventures, Morado Ventures, Norwich Ventures, AME Cloud Ventures

## Investors

- Emergent Medical Ventures (https://capitalatlas.ai/funds/emergent-medical-ventures) — Series A, Series B, Series C
- Asset Management Ventures (https://capitalatlas.ai/funds/asset-management-ventures) — Series A
- Morado Ventures (https://capitalatlas.ai/funds/morado-ventures) — Series A
- Norwich Ventures (https://capitalatlas.ai/funds/norwich-ventures) — Series A
- AME Cloud Ventures (https://capitalatlas.ai/funds/ame-cloud-ventures) — Series A
- GE Capital, Equity (https://capitalatlas.ai/funds/ge-capital-equity) — Series A
- Stanford-StartX Fund — Series A
- Temasek Holdings — Series B, Series C
- Varian Medical Systems, Inc. — Series B, Series C
- Fosun Capital (https://capitalatlas.ai/funds/fosun-capital) — Series B, Series C
- Northwell Holdings (https://capitalatlas.ai/funds/northwell-holdings) — Series B
- GE Ventures — Series B
- ORI Capital (https://capitalatlas.ai/funds/ori-capital) — Series B
- NewYork-Presbyterian Hospital — Series B
- DNA Capital — Series B
- Revelation Partners (https://capitalatlas.ai/funds/revelation-partners) — Series C
- Benslie Investment Group — Series C